Bariatric surgery and kidney disease outcomes in severely obese youth

Petter Bjornstad, Edward Nehus, Daniel van Raalte

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Bariatric surgery, an emerging treatment for severely obese youth with and without T2D, provides marked improvement in insulin resistance, beta-cell function, and central adiposity. Further, preliminary data suggest that bariatric surgery also results in significant improvement in markers of obesity-related nephropathy and DKD, beyond that which can be achieved with current medical interventions. Yet, the mechanisms whereby bariatric surgery attenuates kidney disease remain unclear. This review summarizes the data on the effects of bariatric surgery on obesity-related nephropathy and DKD in youth with and without T2D, in addition to potential mechanisms underlying the nephroprotective effects of weight loss surgery and how these may differ in Roux-en-Y gastric bypass vs. vertical sleeve gastrectomy. Finally, we discuss potential future non-surgical therapies to mitigate kidney disease.
Original languageEnglish
Article number150883
JournalSeminars in Pediatric Surgery
DOIs
Publication statusE-pub ahead of print - 20 Jan 2020

Cite this

@article{394037b4e7884ebeae091ed15e724443,
title = "Bariatric surgery and kidney disease outcomes in severely obese youth",
abstract = "Bariatric surgery, an emerging treatment for severely obese youth with and without T2D, provides marked improvement in insulin resistance, beta-cell function, and central adiposity. Further, preliminary data suggest that bariatric surgery also results in significant improvement in markers of obesity-related nephropathy and DKD, beyond that which can be achieved with current medical interventions. Yet, the mechanisms whereby bariatric surgery attenuates kidney disease remain unclear. This review summarizes the data on the effects of bariatric surgery on obesity-related nephropathy and DKD in youth with and without T2D, in addition to potential mechanisms underlying the nephroprotective effects of weight loss surgery and how these may differ in Roux-en-Y gastric bypass vs. vertical sleeve gastrectomy. Finally, we discuss potential future non-surgical therapies to mitigate kidney disease.",
keywords = "Bariatric surgery, Kidney diease, Pediatric obesity, Type 2 diabetes, Weight loss surgery",
author = "Petter Bjornstad and Edward Nehus and {van Raalte}, Daniel",
year = "2020",
month = "1",
day = "20",
doi = "10.1016/j.sempedsurg.2020.150883",
language = "English",
journal = "Seminars in Pediatric Surgery",
issn = "1055-8586",

}

Bariatric surgery and kidney disease outcomes in severely obese youth. / Bjornstad, Petter; Nehus, Edward; van Raalte, Daniel.

In: Seminars in Pediatric Surgery, 20.01.2020.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Bariatric surgery and kidney disease outcomes in severely obese youth

AU - Bjornstad, Petter

AU - Nehus, Edward

AU - van Raalte, Daniel

PY - 2020/1/20

Y1 - 2020/1/20

N2 - Bariatric surgery, an emerging treatment for severely obese youth with and without T2D, provides marked improvement in insulin resistance, beta-cell function, and central adiposity. Further, preliminary data suggest that bariatric surgery also results in significant improvement in markers of obesity-related nephropathy and DKD, beyond that which can be achieved with current medical interventions. Yet, the mechanisms whereby bariatric surgery attenuates kidney disease remain unclear. This review summarizes the data on the effects of bariatric surgery on obesity-related nephropathy and DKD in youth with and without T2D, in addition to potential mechanisms underlying the nephroprotective effects of weight loss surgery and how these may differ in Roux-en-Y gastric bypass vs. vertical sleeve gastrectomy. Finally, we discuss potential future non-surgical therapies to mitigate kidney disease.

AB - Bariatric surgery, an emerging treatment for severely obese youth with and without T2D, provides marked improvement in insulin resistance, beta-cell function, and central adiposity. Further, preliminary data suggest that bariatric surgery also results in significant improvement in markers of obesity-related nephropathy and DKD, beyond that which can be achieved with current medical interventions. Yet, the mechanisms whereby bariatric surgery attenuates kidney disease remain unclear. This review summarizes the data on the effects of bariatric surgery on obesity-related nephropathy and DKD in youth with and without T2D, in addition to potential mechanisms underlying the nephroprotective effects of weight loss surgery and how these may differ in Roux-en-Y gastric bypass vs. vertical sleeve gastrectomy. Finally, we discuss potential future non-surgical therapies to mitigate kidney disease.

KW - Bariatric surgery

KW - Kidney diease

KW - Pediatric obesity

KW - Type 2 diabetes

KW - Weight loss surgery

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85078498462&origin=inward

U2 - 10.1016/j.sempedsurg.2020.150883

DO - 10.1016/j.sempedsurg.2020.150883

M3 - Article

JO - Seminars in Pediatric Surgery

JF - Seminars in Pediatric Surgery

SN - 1055-8586

M1 - 150883

ER -